-----------------------------
OMB APPROVAL
UNITED STATES -----------------------------
SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058
Washington, D.C. 20549 Expires: April 30, 2009
Estimated average burden
FORM 12b-25 hours per response ..... 2.50
-----------------------------
Commission File Number _____________ -----------------------------
SEC FILE NUMBER
000-33473
NOTIFICATION OF LATE FILING -----------------------------
CUISP NUMBER
92823V202
-----------------------------
(Check One): |X| Form 10-K |_| Form 11-K |_| Form 20-F |_| Form 10-Q
|_| Form N-SAR
For Period Ended: April 30, 2008
--------------
|_| Transition Report on Form 10-K
|_| Transition Report on Form 20-F
|_| Transition Report on Form 11-K
|_| Transition Report on Form 10-Q
|_| Transition Report on Form N-SAR
For the Transition Period Ended:_____________________________
Read attached instruction sheet before preparing form. Please print or
type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION
VIRIDAX CORPORATION
- --------------------------------------------------------------------------------
Full Name of Registrant
I&E TROPICALS, INC.
- --------------------------------------------------------------------------------
Former Name if Applicable
270 N.W. 3RD COURT
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
BOCA RATON, FL 33432-3720
- --------------------------------------------------------------------------------
City, State and Zip Code
PART II - RULE 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate.)
| (a) The reasons described in reasonable detail in Part III of this form
| could not be eliminated without unreasonable effort or expense;
|
| (b) The subject annual report, semi-annual report, transition report on
| Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or portion thereof
| will be filed on or before the 15th calendar day following the
|X| | prescribed due date; or the subject quarterly report or transition
| report on Form 10-Q, or portion thereof will be filed on or before
| the fifth calendar day following the prescribed due date; and
|
| (c) The accountant's statement or other exhibit required by Rule
| 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
Under instructions from our auditor, an independent CPA firm is preparing
an Appraisal Report for Certain Bacteriophage-Based products owned by the
Corporation as of the end of our fiscal year - April 30, 2008. This firm is not
able to complete its report in time to meet the filing of our Form 10-KSB within
the prescribed time.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
LEDYARD H. DEWEES (561) 368-1427
---------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed? If the
answer is no, identify report(s).
|X| Yes |_| No
- --------------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or portion
thereof?
|_| Yes |X| No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
VIRIDAX CORPORATION
--------------------------------------------
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date July 21, 2008 By /s/ Ledyard H. DeWees
------------------- ------------------------------------------
Ledyard H. DeWees, Secretary
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
- --------------------------------------------------------------------------------
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (see 18 U.S.C. 1001).
- --------------------------------------------------------------------------------